1. Home
  2. WNW vs COCH Comparison

WNW vs COCH Comparison

Compare WNW & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meiwu Technology Company Limited

WNW

Meiwu Technology Company Limited

HOLD

Current Price

$1.78

Market Cap

25.8M

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.67

Market Cap

24.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNW
COCH
Founded
2015
1995
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
25.8M
24.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
WNW
COCH
Price
$1.78
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.50
AVG Volume (30 Days)
32.2K
123.6K
Earning Date
05-12-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$2,550,178.00
$208,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
$1.32
N/A
Revenue Growth
570.49
N/A
52 Week Low
$0.95
$0.64
52 Week High
$6.66
$1.91

Technical Indicators

Market Signals
Indicator
WNW
COCH
Relative Strength Index (RSI) 63.30 43.24
Support Level $1.40 $0.64
Resistance Level $1.56 $0.70
Average True Range (ATR) 0.14 0.03
MACD 0.02 0.00
Stochastic Oscillator 84.64 30.89

Price Performance

Historical Comparison
WNW
COCH

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Share on Social Networks: